- A potential role for 6-sulfo sialyl Lewis X in metastasis of bladder urothelial carcinoma.
Taga M, Hoshino H, Low S, Imamura Y, Ito H, Yokoyama O, Kobayashi M.
Urol Oncol. 2015 Nov;33(11):496.e1-9. doi: 10.1016/j.urolonc.2015.05.026. Epub 2015 Jun 29.
PMID: 26137907
- [A case of metachronal testicular tumor eight years after medical treatment of extragonadal germ cell tumor].
Tanio M, Aoki Y, Kobayashi H, Yokoi S, Ito H, Oyama N, Akino H, Yokoyama O.
Hinyokika Kiyo. 2015 Apr;61(4):173-6. Japanese.
PMID: 26037678
- Once-daily oxybutynin patch improves nocturia and sleep quality in Japanese patients with overactive bladder: Post-hoc analysis of a phase III randomized clinical trial.
Yokoyama O, Yamaguchi A, Yoshida M, Yamanishi T, Ishizuka O, Seki N, Takahashi S, Yamaguchi O, Higo N, Minami H, Masegi Y.
Int J Urol. 2015 Jul;22(7):684-8. doi: 10.1111/iju.12755. Epub 2015 Mar 17.
PMID: 25782032
- Effects of the 5α-reductase inhibitor dutasteride on rat prostate α1A-adrenergic receptor and its mediated contractility.
Wang D, Zha X, Nagase K, Akino H, Muramatsu I, Ito H, Yokoyama O.
Urology. 2015 Mar;85(3):704.e9-14. doi: 10.1016/j.urology.2014.12.002.
PMID: 25733305
- Safety and efficacy of mirabegron as 'add-on' therapy in patients with overactive bladder treated with solifenacin: a post-marketing, open-label study in Japan (MILAI study).
Yamaguchi O, Kakizaki H, Homma Y, Igawa Y, Takeda M, Nishizawa O, Gotoh M, Yoshida M, Yokoyama O, Seki N, Okitsu A, Hamada T, Kobayashi A, Kuroishi K.
BJU Int. 2015 Oct;116(4):612-22. doi: 10.1111/bju.13068. Epub 2015 Apr 23.
PMID: 25639296
- Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving α1-blocker treatment: a multi-centre, prospective, randomised study.
Yokoyama O, Tsujimura A, Akino H, Segawa N, Tamada S, Oguchi N, Kitagawa Y, Tsuji H, Watanabe A, Inamoto T, Shimizu N, Fujiuchi Y, Katsuoka Y, Azuma H, Matsuda T, Namiki M, Uemura H, Okuyama A, Nonomura N, Fuse H, Nakatani T.
World J Urol. 2015 May;33(5):659-67. doi: 10.1007/s00345-014-1399-x. Epub 2014 Sep 16.
PMID: 25224929
- Alpha 1-adrenoceptor blocker may improve not only voiding but also storage lower urinary tract symptoms caused by (125) I brachytherapy for prostate cancer.
Oyama N, Aoki Y, Ito H, Miwa Y, Akino H, Sato Y, Shioura H, Kimura H, Yokoyama O.
ISRN Urol. 2014 Mar 30;2014:140654. doi: 10.1155/2014/140654. eCollection 2014.
PMID: 25006516
- [Two cases of epithelioid angiomyolipoma of the kidney].
Kaneda M, Ito H, Horie N, Taga M, Watanabe N, Tadakazu O, Imamura Y, Yokoyama O.
Nihon Hinyokika Gakkai Zasshi. 2013 Nov;104(6):712-5. Japanese.
PMID: 24564079
- Efficacy of fesoterodine on nocturia and quality of sleep in Asian patients with overactive bladder.
Yokoyama O, Hiro S, Hotta S, Mogami S, Yamagami H.
Urology. 2014 Apr;83(4):750-5. doi: 10.1016/j.urology.2013.12.008. Epub 2014 Feb 8.
PMID: 24518285
- Phase III, randomised, double-blind, placebo-controlled study of the β3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder.
Yamaguchi O, Marui E, Kakizaki H, Homma Y, Igawa Y, Takeda M, Nishizawa O, Gotoh M, Yoshida M, Yokoyama O, Seki N, Ikeda Y, Ohkawa S.
BJU Int. 2014 Jun;113(6):951-60. doi: 10.1111/bju.12649. Epub 2014 Mar 17.
PMID: 24471907
5 / 10« 先頭«...456...»最後 »